These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 4433653

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Antagonism of erythropoietin production in rabbits by atropine.
    Paulo LG, Roh BL, Fisher JW.
    Proc Soc Exp Biol Med; 1972 Jan; 139(1):207-10. PubMed ID: 5007463
    [No Abstract] [Full Text] [Related]

  • 24. Dose-related differences in the pharmacodynamic and toxicologic response to a novel hyperglycosylated analog of recombinant human erythropoietin in Sprague-Dawley rats with similarly high hematocrit.
    Andrews DA, Boren BM, Turk JR, Boyce RW, He YD, Hamadeh HK, Mytych DT, Barger TE, Salimi-Moosavi H, Sloey B, Elliott S, McElroy P, Sinclair AM, Shimamoto G, Pyrah IT, Lightfoot-Dunn RM.
    Toxicol Pathol; 2014 Jan; 42(3):524-39. PubMed ID: 23674391
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Erythropoiesis and iron metabolism in experimental inflammation. Preliminary report].
    Ganzoni AM, Forrer P, Rüttimann G, Baviera B, Rhyner K.
    Schweiz Med Wochenschr; 1974 Jan 26; 104(4):145-6. PubMed ID: 4811474
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Mechanism of thyroxine action on erythropoiesis.
    Peschle C, Zanjani ED, Gidari AS, McLaurin WD, Gordon AS.
    Endocrinology; 1971 Aug 26; 89(2):609-12. PubMed ID: 5558006
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Mode of action of erythropoietin in polycythemic mice. II. Response in mice with polycythemia induced by hypoxia or transfusion.
    McDonald TP, Lange RD, Kretchmar AL.
    J Lab Clin Med; 1971 Jan 26; 77(1):134-43. PubMed ID: 5540422
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Inhibitory effect of glucagon on erythropoiesis.
    Naets JP, Guns M.
    Blood; 1980 Jun 26; 55(6):997-1002. PubMed ID: 7378587
    [No Abstract] [Full Text] [Related]

  • 36. Studies of the hemopoietic microenvironment. V. Erythropoietin-induced release of vasoactive substance(s) from erythropoietin-responsive stem cells (39902).
    McCuskey RS, Meineke HA.
    Proc Soc Exp Biol Med; 1977 Oct 26; 156(1):181-5. PubMed ID: 909886
    [No Abstract] [Full Text] [Related]

  • 37. DNA polymerase activities during erythropoiesis. Effects of erythropietin, vinblastine, colcemid, and daunomycin.
    Roodman GD, Hutton JJ, Bollum FJ.
    Exp Cell Res; 1975 Mar 15; 91(2):269-78. PubMed ID: 1126385
    [No Abstract] [Full Text] [Related]

  • 38. Response in mice to an erythropoietin-generating factor.
    Lewis JP, Welch ET, Neal WA, Wright CS, Smith LL, Lange RD.
    Am J Vet Res; 1975 Jul 15; 36(7):1057-9. PubMed ID: 1173743
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.